Skip to main content

Portfolio

*WHO licensure prequalification

Vaccines(Vx), Therapeutics(Tx)
Focus field Project title Research institute Development stage
Pre-clinical Phase1 Phase2 Phase3 Licensure
Vaccines (Vx) Low-cost HepAVaccine Manufacturing Platform
Novel Cholera Conjugate Vaccine
Pentavalent Meningitis Conjugate Vaccine
Prime-Boost BCG Vaccine
Development of a sublingual COVID-19 subunit vaccine
Schistosomiasis vaccine
Typhoid Conjugate Vaccine
Measles-Rubella MAP vaccine
Group A Streptococcus vaccine
Therapeutics (Tx) Continuous Manufacturing Process for New Antimalarial
Antimalarial combination therapy for malaria prevention
Development of a therapeutic anti-dengue polymeric IgG antibody
Continuous manufacturing process for visceral leishmaniasis drug
Continuous manufacturing process for human use helminth infection treatment
Novel antibiotic combinations to address AMR burden in neonatal sepsis
Treatment development for severe malaria
Single exposure radical cure for blood stage malaria
Diagnostics(Dx), Digital Health(DH)
Focus field Project title Research institute Development stage
Early Validation Late Validation Clinical Validation Licensure
Diagnostics (Dx) Leishmaniasis RDT Cartridge and Mobile Pocket Analyzer
2nd Generation TB LAM Assay
AI-driven All-in-One Diagnostic platform for Malaria Species Differentiation
In vitro Diagnostics Test for Severe Fever and thrombocytopenia Syndrome
POCT for Pyrazinamide (PZA) Susceptibility Testing
POCT for Multidrug-Resistant TB
POCT for COVID19, Influenza and RSV

*WHO licensure prequalification

Vaccines(Vx)
Project title Research institute Development stage Current state
Pre-clinical Phase1 Phase2 Phase3 Licensure
DTwP-HepB-Hib Pentavalent MAP Vaccine Completed
Low-cost HepAVaccine Manufacturing Platform Completed
Prime-Boost BCG Vaccine Suspended
COVID-19 Vaccine Using Viral Vector System Completed
DNA Vaccine Using Electro-Portable MicroneedlePatch Completed
Intranasal Universal Respiratory Virus Vaccine Completed
Microneedle-mediated SARS-CoV-2 DNA Vaccine Completed
Mpg loaded TB MAP Vaccine Completed
Non-replicating Protein Nanoparticles-based Rotavirus Vaccine Completed
SARS-CoV-2 Nanogel Sublingual Vaccine Suspended
Virus-free Recombinant Polio Vaccine Suspended
Development of a sublingual COVID-19 subunit vaccine Completed
Novel Cholera Conjugate Vaccine Completed
Quadrivalent Meningitis Conjugate Vaccine Suspended
Pentavalent Meningitis Conjugate Vaccine In progress
Schistosomiasis vaccine In progress
DTwP-HepB-IPV-Hib Hexavalent Vaccine Completed
Typhoid Conjugate Vaccine In progress
Measles-Rubella MAP vaccine In progress
Group A Streptococcus vaccine In progress

*WHO licensure prequalification

Vaccines(Vx)
Project title Research institute Development stage
Pre-clinical Phase1 Phase2 Phase3 Licensure
Low-cost HepAVaccine Manufacturing Platform
DTwP-HepB-Hib Pentavalent MAP Vaccine
Novel Cholera Conjugate Vaccine
COVID-19 Vaccine Using Viral Vector System
DNA Vaccine Using Electro-Portable MicroneedlePatch
Intranasal Universal Respiratory Virus Vaccine
Microneedle-mediated SARS-CoV-2 DNA Vaccine
Mpg loaded TB MAP Vaccine
Non-replicating Protein Nanoparticles-based Rotavirus Vaccine
DTwP-HepB-IPV-Hib Hexavalent Vaccine
Measles-Rubella MAP vaccine

*WHO licensure prequalification

Vaccines(Vx)
Project title Research institute Development stage
Pre-clinical Phase1 Phase2 Phase3 Licensure
Pentavalent Meningitis Conjugate Vaccine
Schistosomiasis vaccine
Typhoid Conjugate Vaccine
Measles-Rubella MAP vaccine
Group A Streptococcus vaccine

*WHO licensure prequalification

Vaccines(Vx)
Project title Research institute Development stage
Pre-clinical Phase1 Phase2 Phase3 Licensure
SARS-CoV-2 Nanogel Sublingual Vaccine
Virus-free Recombinant Polio Vaccine
Quadrivalent Meningitis Conjugate Vaccine
Prime-Boost BCG Vaccine

*WHO licensure prequalification

Therapeutics(Tx)
Project title Research institute Development stage Current state
Pre-clinical Phase1 Phase2 Phase3 Licensure
Development of a therapeutic anti-dengue polymeric IgG antibody Suspended
NiclosamideIntramuscularDepotInjectionfor Dengue VirusDisease Suspended
Safety assessment of TTCA antitubercular agents Completed
Novel route of synthesis of antimalarial drug Suspended
Antimalarial combination therapy for malaria prevention In progress
Continuous manufacturing process for visceral leishmaniasis drug Completed
Continuous Manufacturing Process for New Antimalarial Completed
Continuous manufacturing process for human use helminth infection treatment In progress
Novel antibiotic combinations to address AMR burden in neonatal sepsis In progress
Treatment development for severe malaria In progress
Single exposure radical cure for blood stage malaria In progress

*WHO licensure prequalification

Therapeutics(Tx)
Project title Research institute Development stage
Pre-clinical Phase1 Phase2 Phase3 Licensure
Safety assessment of TTCA antitubercular agents
Continuous manufacturing process for visceral leishmaniasis drug
Continuous Manufacturing Process for New Antimalarial

*WHO licensure prequalification

Therapeutics(Tx)
Project title Research institute Development stage
Pre-clinical Phase1 Phase2 Phase3 Licensure
Antimalarial combination therapy for malaria prevention
Continuous manufacturing process for human use helminth infection treatment
Novel antibiotic combinations to address AMR burden in neonatal sepsis
Treatment development for severe malaria
Single exposure radical cure for blood stage malaria

*WHO licensure prequalification

Therapeutics(Tx)
Project title Research institute Development stage
Pre-clinical Phase1 Phase2 Phase3 Licensure
NiclosamideIntramuscularDepotInjectionfor Dengue VirusDisease
Novel route of synthesis of antimalarial drug
Development of a therapeutic anti-dengue polymeric IgG antibody

*WHO licensure prequalification

Diagnostics(Dx)
Project title Research institute Development stage Current state
Early Validation Late Validation Clinical Validation Licensure
Leishmaniasis RDT Cartridge and Mobile Pocket Analyzer In progress
In vitro Diagnostics Test for Severe Fever and thrombocytopenia Syndrome Suspended
Instrument-free molecular diagnostic platform for COVID-19 Completed
Mobile Diagnostic Platform for Influenza and SARS-CoV-2 Completed
POCT for Pyrazinamide (PZA) Susceptibility Testing Completed
Quantitative POC Test Using mBFPfor G6PD Deficiency Completed
Rapid Diagnostic Test for Both S.Typhiand S.ParatyphiA Suspended
Rapid Diagnostic Test for Chikungunya Antigen Completed
Rapid Diagnostic Test for Visceral Leishmaniasis Antigen Suspended
SurearlySmartPro COVID-19 Completed
2nd Generation G6PD Test Completed
2nd Generation TB LAM Assay Completed
POCT for Multidrug-Resistant TB Completed
Validation of All-in-One Device for Malaria Diagnosis Completed
AI-driven All-in-One Diagnostic platform for Malaria Species Differentiation In progress
POCT for COVID19, Influenza and RSV In progress

*WHO licensure prequalification

Diagnostics(Dx)
Project title Research institute Development stage
Early Validation Late Validation Clinical Validation Licensure
Instrument-free molecular diagnostic platform for COVID-19
Mobile Diagnostic Platform for Influenza and SARS-CoV-2
Quantitative POC Test Using mBFPfor G6PD Deficiency
Rapid Diagnostic Test for Chikungunya Antigen
SurearlySmartPro COVID-19
2nd Generation G6PD Test
Validation of All-in-One Device for Malaria Diagnosis
POCT for Pyrazinamide (PZA) Susceptibility Testing
2nd Generation TB LAM Assay
POCT for Multidrug-Resistant TB

*WHO licensure prequalification

Diagnostics(Dx)
Project title Research institute Development stage
Early Validation Late Validation Clinical Validation Licensure
Leishmaniasis RDT Cartridge and Mobile Pocket Analyzer
AI-driven All-in-One Diagnostic platform for Malaria Species Differentiation
POCT for COVID19, Influenza and RSV

*WHO licensure prequalification

Diagnostics(Dx)
Project title Research institute Development stage
Early Validation Late Validation Clinical Validation Licensure
Rapid Diagnostic Test for Both S.Typhiand S.ParatyphiA
Rapid Diagnostic Test for Visceral Leishmaniasis Antigen
In vitro Diagnostics Test for Severe Fever and thrombocytopenia Syndrome

*WHO licensure prequalification

Digital Health(DH)
Project title Research institute Development stage Current state
Early Validation Late Validation Clinical Validation Licensure
AI-Driven Platform for Anti-Tubercular Drug Discovery Completed
Data Platform to Improve Diagnosis of Infectious Diseases Completed
ICT based Self-risk Assessment Platform for COVID-19 Completed
Chest X-ray AI for COVID-19 Suspended

*WHO licensure prequalification

Digital Health(DH)
Project title Research institute Development stage
Early Validation Late Validation Clinical Validation Licensure
Validation of All-in-One Device for Malaria Diagnosis
Data Platform to Improve Diagnosis of Infectious Diseases
ICT based Self-risk Assessment Platform for COVID-19
No information yet.

*WHO licensure prequalification

Digital Health(DH)
Project title Research institute Development stage
Early Validation Late Validation Clinical Validation Licensure
Chest X-ray AI for COVID-19
Evidence Generation Award In progress
Project title Research institute Study Area/Country
The impact of digital health technologies on the delivery of maternal and child health services; A case study of Uganda Uganda
DigiHLab: Assessment of digital health tools for laboratory diagnosis of endemic and pandemic diseases Mozambique
Multidisciplinary analysis of digitally preventable health system gap for crisis-affected population in Ethiopia, Nepal, and Kiribati Ethiopia, Nepal, Kiribati
The PAMODZI COVID 19 study: The public health assessment of Malawi’s one digitized infrastructure COVID 19 Study Malawi
Digital tools applicability for community surveillance of infectious disease Nigeria
EVALUATE: Estimating the value-add of Lunit software’s use to accelerate TB elimination Vietnam
No information yet.
No information yet.
Evidence Generation Award
Project title Research institute Study Area/Country Current state
The impact of digital health technologies on the delivery of maternal and child health services; A case study of Uganda Uganda In progress
DigiHLab: Assessment of digital health tools for laboratory diagnosis of endemic and pandemic diseases Mozambique In progress
Multidisciplinary analysis of digitally preventable health system gap for crisis-affected population in Ethiopia, Nepal, and Kiribati Ethiopia, Nepal, Kiribati In progress
The PAMODZI COVID 19 study: The public health assessment of Malawi’s one digitized infrastructure COVID 19 Study Malawi In progress
Digital tools applicability for community surveillance of infectious disease Nigeria In progress
EVALUATE: Estimating the value-add of Lunit software’s use to accelerate TB elimination Vietnam In progress

Receive newsletters from the RIGHT Foundation by e-mail